SCHEMBL20152906

SCHEMBL20152906

CC(=O)c1cccc2nc3n(c(=O)c12)CCN(C(=O)OC(C)(C)C)C3

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.45
TNKS2 Q9H2K2 1/20 0.45
PARP2 Q9UGN5 1/20 0.45
NR1H2 P55055 1/20 0.41
POLB P06746 1/20 0.40
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OGFRL1 Q5TC84 1/20 0.37
MAPK1 P28482 1/20 0.37
MAP4K4 O95819 1/20 0.37
POLR1A O95602 1/20 0.36
GBA1 P04062 2/20 0.36
PTPN11 Q06124 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
DTYMK P23919 2/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20036990 0.90 NR1H2 (0.49) PARP1TNKS2PARP2NR1H2POLB
SCHEMBL20152907 0.82 PARP1 (0.42) PARP1TNKS2PARP2TSHRHTT
SCHEMBL20139779 0.78 TSHR (0.62) NR1H2POLBTSHRHTTOPRM1
SCHEMBL31029028 0.76 NR1H2 (0.44) PARP1TNKS2PARP2NR1H2POLB
SCHEMBL27432553 0.76 NR1H2 (0.44) PARP1TNKS2PARP2NR1H2POLB
SCHEMBL20161153 0.73 ALDH1A1 (0.43) PARP1TNKS2PARP2TSHRHTT
SCHEMBL20152908 0.72 ALDH1A1 (0.35) PARP1POLBMAPK1
SCHEMBL1231827 0.72 GBA1 (0.44) NR1H2POLBTSHRHTTMAPK1
SCHEMBL13575666 0.70 CKS1B (0.48) NR1H2TSHRMAPK1GBA1LIPG
SCHEMBL27432394 0.70 NR1H2 (0.45) PARP1TNKS2PARP2NR1H2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134722-A1 AZA-PHENALENE-3-KETONE DERIVATIVE, PREPARATION METHOD THEREOF, AND ITS APPLICATION AS PARP INHIBITOR SUZHOU KANGRUN PHARMACEUTICALS INC. (CN) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134722-A1 AZA-PHENALENE-3-KETONE DERIVATIVE, PREPARATION METHOD THEREOF, AND ITS APPLICATION AS PARP INHIBITOR PARP1, PARP11, PARP3 PARP1 1/4885TNKS2 33/4885PARP2 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.